ArticleResearch and practice in thrombosis and haemostasis2025
Heavy or healthy? Assessing menstrual bleeding and bleeding tendency in Dutch adolescents.
Article in Research and practice in thrombosis and haemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Call to action: identifying an underlying bleeding disorder in adolescents with heavy menstrual bleeding.Research and practice in thrombosis and haemostasis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heavy menstrual bleeding (HMB) is common in adolescents and may indicate a bleeding disorder. The pictorial blood loss assessment chart (PBAC) defines HMB as a score ≥150, while an elevated self-bleeding assessment tool (self-BAT) score identifies people at risk for a bleeding disorder (age 12-17 years ≥3 and 18-21 years ≥6). PBAC and self-BAT scores from the general menstruating population are, however, unknown. Objectives: To assess the prevalence and association of HMB and elevated self-BAT scores in adolescents. Methods: Adolescents (aged 12-21 years) using the Menstruation Education Calendar application were included if they had completed the self-BAT and ≥1 PBAC. The Menstruation Education Calendar application is a mobile Health intervention and facilitates monitoring of menstrual blood loss. Logistic regression was used to assess the association between PBAC ≥150 and elevated self-BAT scores. Results: Between 2023 and 2024, 330 adolescents completed the workup. Of the participants, 22.1% (n=73/330) had a PBAC score ≥150, and 16.4% (n = 54/330) had an elevated self-BAT score. PBAC scores ≥150 were associated with an increased risk for an elevated self-BAT (odds ratio [OR], 2.48; 95% CI, 1.32-4.64). PBAC score ≥150 was equally prevalent in adolescents aged between 12 and 17 and 18 and 21 years (OR 0.70; 95% CI, 0.37-1.31). Adolescents aged 18 to 21 years had a lower risk for an elevated self-BAT compared with those aged 12 to 17 years (OR, 0.11; 95% CI, 0.06-0.20). Conclusion: Of adolescents, 20% have HMB. In adolescents aged 12 to 17 years, the self-BAT cutoff score ≥3 is too sensitive, identifying ∼50% at risk for a bleeding disorder and strengthening the need for reassessing the self-BAT cutoff score in menstruating adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.